Back to dashboard
Episode 359
DIP Episode 359 - The Clutch Hypersensitivity Reactions Podcast (for Step 1-3)
Biostatistics/EthicsMedium4 - HighHas Q&A
Step 1Step 2Step 3MedicineUSMLEStep 1Step 2Step 3
Topic
Hypersensitivity reactions; Type I (IgE); Type II (Antibody-mediated); Type III (Immune Complex); Type IV (Delayed T-cell mediated)
Key Takeaway
Understanding the four major types of hypersensitivity reactions—Type I ({IgE}), Type II ({IgG/IgM}), Type III (immune complexes), and Type IV ({T}-cells)—is critical for diagnosing autoimmune, allergic, and inflammatory conditions on board exams.
Runtime: 27 min
Published: 2021-12-29
Completed audio: Yes
Completed notes: Yes
Anki made: Yes
Section: —
Episode Notes
Source / episode info
- Episode: 359
- Title: Divine Intervention Episode 359 – The Clutch Hypersensitivity Reactions Podcast (for Step 1-3)
- Published: 2021-12-29
- Source: Episode page
One-liner
This episode provides a comprehensive review of the four major types of hypersensitivity reactions, detailing their specific mediators (IgE, IgG/IgM, immune complexes, T-cells), mechanisms (complement activation, degranulation, deposition), and classic clinical examples like asthma, Goodpasture syndrome, serum sickness, and poison ivy.
High-yield summary
- Type I Hypersensitivity: Immediate reaction mediated by {IgE} antibodies bound to mast cells/basophils; involves cross-linking upon re-exposure, leading to degranulation (histamine release) and symptoms like asthma or anaphylaxis.
- Type II Hypersensitivity: Antibody-mediated destruction of self-antigens ({RB Cs}, {platelets}); relies on {IgG} and {IgM} binding to the antigen, activating the Classic Complement Cascade (leading to MAC formation).
- Type III Hypersensitivity: Mediated by circulating, mobile immune complexes ({Antigen-Antibody}) that deposit in tissues (e.g., glomeruli, joints), triggering complement activation and vasculitis/nephritis.
- Type IV Hypersensitivity: Delayed reaction mediated primarily by {T}-cells (CD4^+ T_H1) and macrophages; involves antigen presentation on MHC II followed by the release of Interferon Gamma ({IFN-}), which activates macrophages to cause local tissue damage.
- Key Clinical Pearls: Anaphylactic transfusion reactions are classic Type I events, often seen in {IgA} deficiency. Goodpasture syndrome is a Type II example (anti-Type IV collagen). Serum sickness and post-streptococcal glomerulonephritis are classic Type III examples.
Learning objectives
- Differentiate the mechanisms and mediators of Type I, II, III, and IV hypersensitivity reactions.
- Recognize classic clinical presentations associated with each type (e.g., asthma -> Type I; Goodpasture -> Type II).
- Understand the role of key immune components (\text{IgE}, complement cascade, \text{IFN-}\gamma) in mediating tissue damage.
- Correlate specific autoimmune conditions (e.g., lupus nephritis, RA) with their underlying hypersensitivity type.
- Identify appropriate emergency management for severe allergic reactions (epinephrine).
Board exam buzzwords
| Condition | Key Finding | Association | Board Exam Tip |
| Asthma/Anaphylaxis | Wheezing, bronchospasm | {IgE} mediated; Mast cell degranulation | Always think Type I. Treatment priority is epinephrine for airway stabilization. |
| Goodpasture Syndrome | Hemoptysis + Hematuria | Anti-Type IV collagen antibodies | Classic example of Type II hypersensitivity targeting basement membranes. |
| Serum Sickness | Polyarthralgia, fever, rash (3 weeks post-infusion) | Circulating {Ag-Ab} complexes | The hallmark is the deposition of mobile immune complexes ({Type III}). |
| Poison Ivy/Contact Dermatitis | Delayed skin reaction | T-cell activation; Macrophage infiltration | If "delayed" or involves contact, think Type IV. {IFN-} is the key cytokine. |
Rapid review table
| Topic | Key Point | Context | Exam Relevance |
| Type I | Mediator: {IgE} | Allergen exposure (e.g., pollen, food) | Immediate reaction; mast cell degranulation causes histamine release. |
| Type II | Mediator: {IgG/IgM} | Self-antigen binding (e.g., RB Cs, platelet glycoproteins) | Activates the classic complement cascade; positive Coombs test is diagnostic evidence of antibody involvement. |
| Type III | Mediator: Immune Complexes ({Ag-Ab}) | Systemic deposition in small vessels/tissues | Causes vasculitis and glomerulonephritis (e.g., post-strep). |
| Type IV | Mediator: {T}-cells, Macrophages | Delayed contact with antigen (e.g., poison ivy) | Requires CD4^+ T_H1 cells releasing {IFN-}; the reaction is delayed by 24-72 hours. |
Board-speak -> diagnosis
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A 24-year-old female presents with wheezing, cough worse at night, and shortness of breath in cold weather. | Asthma (Type I Hypersensitivity) | Classic presentation of bronchial hyperreactivity due to {IgE}-mediated mast cell degranulation upon allergen exposure. |
| A patient develops joint pain and kidney damage three weeks after receiving a monoclonal antibody infusion for malignancy. | Serum Sickness (Type III Hypersensitivity) | The reaction is caused by the deposition of circulating immune complexes ({Ag-Ab}) in tissues, triggering complement activation. |
| A child presents with hemoptysis, hematuria, and positive Coombs test following an unknown illness. | Goodpasture Syndrome (Type II Hypersensitivity) | Autoantibodies target Type IV collagen in the basement membranes of the lungs and kidneys; the positive Coombs test confirms antibody mediation. |
| A patient develops a rash and dermatitis after handling poison ivy. | Contact Dermatitis (Type IV Hypersensitivity) | The reaction is delayed, involving T-cell activation ({IFN-} release) and macrophage infiltration, not immediate {IgE} release. |
| A blood transfusion causes acute flushing, hypotension, and hematuria shortly after the start of the unit. | Acute Hemolytic Transfusion Reaction (Type II Hypersensitivity) | Preformed {IgG/IgM} antibodies bind to transfused red blood cells, activating complement and causing rapid hemolysis. |
| A patient presents with polyarthritis and skin lesions following an upper respiratory infection 3 weeks prior. | Post-streptococcal Glomerulonephritis (Type III Hypersensitivity) | Immune complexes form between streptococcal antigens and host antibodies, depositing in the glomeruli. |
Differential diagnosis / distinguishing features
Type III vs Type IV Hypersensitivity
| Key Features | Distinguishing Findings | Next Step |
| Type III: Immune complex deposition ({Ag-Ab} complexes). Symptoms: Vasculitis, nephritis (glomerulonephritis), polyarthritis. | Type IV: T-cell mediated; requires antigen presentation and {IFN-}. Delayed onset (24-72 hours). | If symptoms are systemic/multi-organ failure due to deposition -> Type III; if skin/tissue reaction is delayed after contact -> Type IV. |
Autoimmune Hemolytic Anemia
| Key Features | Distinguishing Findings | Next Step |
| Antibody Mediated (Type II): Positive Coombs test, hemolysis due to complement activation. | Non-antibody mediated: Negative Coombs test; hemolysis due to enzyme deficiency or membrane defect (e.g., G6 PD). | Perform direct Coombs test to confirm antibody involvement. If positive, treat the underlying autoimmune process. |
Management pearls
- For suspected anaphylaxis/severe Type I reaction: Epinephrine is the drug of choice; it counteracts bronchoconstriction and hypotension.
- In cases of acute hemolytic transfusion reactions (Type II): Immediate cessation of transfusion, supportive care, and monitoring for signs of DIC.
- When diagnosing glomerulonephritis following infection (potential Type III): Urinalysis should show hematuria and proteinuria; biopsy may reveal immune complex deposition.
- For suspected contact dermatitis or delayed skin reaction (Type IV): Identification of the causative allergen/irritant is key; treatment involves topical steroids and avoidance.
Don't miss
🚨
\text{IgE}: The primary mediator for Type I reactions, binding to mast cells via \text{Fc}\epsilon\text{RI}.
🚨
Complement Cascade: Activation by \text{IgG/IgM} (Type II) leads to the formation of the Membrane Attack Complex (\text{MAC}).
🚨
\text{IFN-}\gamma: The critical cytokine released by CD4^+ T_H1 cells that activates macrophages, driving Type IV pathology.
🚨
Bilirubinemia Trap: If indirect hyperbilirubinemia is due to a non-\text{UDPGT} enzyme defect (e.g., hemolysis), direct bilirubin will likely also be elevated because \text{UDPGT} is functioning normally.
Integration & clinical reasoning
- Immunology & Nephrology: Understanding the difference between Type II (anti-GBM disease/Goodpasture) and Type III (post-strep GN) glomerulonephritis is crucial for differentiating primary vs secondary kidney injury.
- Allergy & Pulmonology: Asthma is the quintessential example of Type I hypersensitivity, requiring recognition of its underlying \text{IgE} mechanism and triggers.
- Hematology: The positive Coombs test strongly suggests an antibody-mediated process (Type II), distinguishing it from non-immune causes of hemolysis (e.g., G6 PD deficiency).
Concept connections / cross-references
- For detailed information on complement activation pathways: [Episode 12]
- For general immunology and T-cell function: [Episode 45]
- For understanding autoimmune diseases like Lupus Nephritis: [Episode 78]
High-yield association table
| Condition | Association | Mechanism | Clinical Significance |
| Asthma | Allergen exposure, {IgE} | Mast cell degranulation upon cross-linking of {IgE}. | Requires immediate epinephrine administration; late phase inflammation is key. |
| Goodpasture Syndrome | Anti-Type IV collagen antibodies | Type II hypersensitivity targeting basement membranes (lungs/kidneys). | Leads to rapidly progressive glomerulonephritis and hemoptysis; requires plasmapheresis. |
| Serum Sickness | Monoclonal antibody infusion, antitoxins | Deposition of circulating {Ag-Ab} complexes ({Type III}). | Diagnosis is clinical/temporal (3 weeks post-infusion); treatment often involves steroids/plasma exchange. |
| Poison Ivy Dermatitis | Plant antigens (urushiol) | T-cell activation (CD4^+ T_H1) and macrophage infiltration ({IFN-}). | Classic example of delayed, Type IV hypersensitivity; emphasizes the role of {IFN-}. |
Key terms glossary
| Term | Definition | Context | Example |
| {IgE} | Immunoglobulin E. The antibody class responsible for immediate allergic reactions. | Type I Hypersensitivity. Binds to mast cells via {Fc}{RI}. | Found in high levels during asthma or anaphylaxis. |
| Complement Cascade | A cascade of plasma proteins that, when activated, leads to the formation of the Membrane Attack Complex ({MAC}). | Type II Hypersensitivity. Activated by {IgG} and {IgM}. | Leads to lysis (explosion) of target cells (e.g., RB Cs). |
| {IFN-} | Interferon Gamma. A potent cytokine released primarily by T_H1 cells. | Type IV Hypersensitivity. Activates macrophages and drives inflammation. | Key mediator in contact dermatitis and tuberculosis pathology. |
| Immune Complex | A complex formed by the binding of an antigen to an antibody ({Ag-Ab}). | Type III Hypersensitivity. Deposition triggers complement activation and vasculitis. | Found in serum during conditions like lupus nephritis or post-strep GN. |
Study optimization
| Topic | Study Approach | Priority | Resources |
| Hypersensitivity Mechanisms | Create a flow chart for all four types, mapping Mediator -> Mechanism -> Clinical Example. | High (Board staple) | Review board-specific mnemonics and classic associations (e.g., Type I = IgE; Type II = Complement). |
| Autoimmune Disease Correlation | Practice linking specific symptoms/labs to the correct type of hypersensitivity (e.g., positive Coombs -> Type II). | Medium-High | Review nephrology and rheumatology sections for common autoimmune presentations. |
| Emergency Management | Memorize the immediate treatment steps for anaphylaxis ({Epinephrine} first) vs. acute transfusion reactions. | High (Clinical application) | Focus on drug mechanisms and contraindications in emergency settings. |
Question pattern recognition
- Pattern: Wheezing/Bronchospasm + Allergen Exposure -> Type I Hypersensitivity. This points to mast cell degranulation mediated by \text{IgE}.
- Pattern: Hemoptysis + Hematuria + Positive Coombs Test -> Type II Hypersensitivity (Anti-GBM Disease). The combination of symptoms and lab findings is highly specific.
- Pattern: Fever/Arthralgia/Rash 3 weeks after infusion of monoclonal antibody -> Type III Hypersensitivity (Serum Sickness). Time course and trigger are key diagnostic clues for immune complex deposition.
Test yourself
Common mistakes to avoid
🚫
Mistake 1 (Type III vs II): Confusing immune complex deposition (Type III) with direct antibody binding to a fixed structure (Type II). Remember: Type III complexes are mobile and deposit; Type II antibodies bind to a specific, often stable, target.
🚫
Mistake 2 (Delayed Reaction): Assuming all delayed reactions are Type IV. While most are, some autoimmune conditions can involve both Type II and Type IV components (e.g., Hashimoto's). Always identify the primary mediator (\text{T}-cell vs \text{IgG}).
🚫
Mistake 3 (Transfusion Reactions): Failing to differentiate between acute hemolytic transfusion reactions (Type II) and anaphylactic transfusion reactions (Type I, often due to IgA deficiency).
Common traps
⚠️
Trap 1: The "Delayed" Trap: If a reaction is delayed but involves \text{IgE} or mast cells, it might be Type I (e.g., late-phase asthma inflammation). Always consider the mediator first.
⚠️
Trap 2: Autoimmune Hemolysis: A positive Coombs test suggests Type II, but remember that non-antibody mediated hemolysis (like G6 PD deficiency) will have a negative Coombs test and is not an antibody-mediated process.
⚠️
Trap 3: The "Glomerulonephritis" Trap: Glomerulonephritis can be caused by Type II (anti-GBM), Type III (post-strep/lupus), or even complement dysregulation, requiring careful clinical correlation and biopsy findings to distinguish the mechanism.
OMM / COMLEX integration
🦴
High-Yield Viscerosomatics, Autonomics & COMAT Shelf Clinical Pearls:
- Autonomic Nervous System Equilibrium: Homeostatic balance requires coordination between sympathetic thoracolumbar outflow (T1–L2) and parasympathetic craniosacral outflow (CN III, VII, IX, X and S2–S4). Tissue texture abnormalities (hypertonicity, boggy edema, moisture) at specific vertebral levels reflect visceral dysfunction.
- Lymphatic Circulation & Diaphragmatic Function: The four major transverse fascial diaphragms (tentorium cerebelli, thoracic inlet, thoracoabdominal diaphragm, and pelvic floor) must move freely in synchrony with respiration to ensure efficient venous return and metabolic clearance.
- COMLEX Board Strategy: Always evaluate the anatomical spinal segment corresponding to the patient's presenting symptom. Correcting somatic dysfunctions at key transitional junctions (OA, C7–T1, T12–L1, L5–S1) improves systemic neurovascular dynamics.